Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 26, 2020
Previous Article Next Article

Synthesis, structure and characterization of new dithiocarbazate-based mixed ligand oxidovanadium(iv) complexes: DNA/HSA interaction, cytotoxic activity and DFT studies

Author affiliations

Abstract

Three new mixed-ligand oxidovanadium(IV) complexes [VIVOL1–2(LN–N)] (1–3) have been synthesized using two tridentate bi-negative –ONS chelating dithiocarbazate ligands, H2L1-2, where H2L1 = S-methyl 3-(2-hydroxynaphthyl)methylenedithiocarbazate, and H2L2 = 4-chloro-S-benzyl 3-(2-hydroxy-4-diethylaminophenyl)methylenedithiocarbazate and neutral N,N-donor bases (LN–N) like 1,10-phenanthroline (phen) (1 and 2) and 2,2′-bipyridine (bipy) (3) as a co-ligand. All the ligands and their corresponding metal complexes have been successfully characterized using several physicochemical (elemental analysis), spectroscopic (UV-vis, IR and EPR), spectrometric (ESI-MS) and electrochemical (cyclic voltammetry) methods. The geometry of the complexes was determined by X-ray diffraction analysis and also optimized using density functional theory (DFT) calculations, which revealed that the compounds possess a distorted octahedral geometry with tridentate dianionic L1-2 in the meridional arrangement and bidentate co-ligand LN–N with an equatorial–axial coordination. To evaluate the biological activity of the oxidovanadium(IV) species, their interactions with calf thymus-DNA (CT-DNA) and human serum albumin (HSA) were studied through UV-vis absorption titration and fluorescence spectral methods. The results indicated that all the complexes have moderate binding affinity towards both DNA and HSA. Finally, the in vitro antiproliferative activity of all the complexes was evaluated against human cervical cancer (HeLa) and mouse embryonic fibroblast (NIH-3T3) cell lines by MTT assay and the results suggested that the complexes were significantly active compared to various clinically reported drugs.

Graphical abstract: Synthesis, structure and characterization of new dithiocarbazate-based mixed ligand oxidovanadium(iv) complexes: DNA/HSA interaction, cytotoxic activity and DFT studies

Back to tab navigation

Supplementary files

Article information


Submitted
12 Mar 2020
Accepted
30 May 2020
First published
01 Jun 2020

New J. Chem., 2020,44, 10946-10963
Article type
Paper

Synthesis, structure and characterization of new dithiocarbazate-based mixed ligand oxidovanadium(IV) complexes: DNA/HSA interaction, cytotoxic activity and DFT studies

A. Banerjee, M. Mohanty, S. Lima, R. Samanta, E. Garribba, T. Sasamori and R. Dinda, New J. Chem., 2020, 44, 10946
DOI: 10.1039/D0NJ01246G

Social activity

Search articles by author

Spotlight

Advertisements